2018 Innovator Under 35: Minmin Yen
Minmin Yen, PhagePro
September 13, 2018 | EmTech
Cholera kills, and vaccines don’t always work. She created a better solution.
Minmin Yen, CEO and Cofounder, PhagePro
Dr. Minmin Yen researched the use of phages as an intervention for cholera during her thesis work in the Camilli Lab at Tufts University, resulting in publications in Nature Communications and eLife. As an undergraduate in biological engineering at MIT, she trained with Professors David Schauer and Darrell Irvine and researched oral vaccine delivery. Passionate about developing innovative solutions for infectious diseases, Dr. Yen was awarded the Howard Hughes Medical Institute MERGE-ID fellowship, which focused on translating bench science to clinical applications, for her graduate education. She traveled to Haiti to study the cholera epidemic and, with Professor Andrew Camilli and postdoctoral researcher Dr. Lynne Cairns, founded PhagePro with the aim of developing phage therapies to help the world’s most vulnerable communities.
Innovators Under 35
individuals whose superb technical work promises to shape the coming decades through the development of new technology or the creative application of existing technologies to solve problems.